| # | Title | Journal | Year | Citations |
|---|
| 1 | Two pathogenetic types of endometrial carcinoma | Gynecologic Oncology | 1983 | 2,076 |
| 2 | A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study | Gynecologic Oncology | 2004 | 1,531 |
| 3 | Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study | Gynecologic Oncology | 1991 | 1,226 |
| 4 | A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study | Gynecologic Oncology | 1999 | 1,082 |
| 5 | Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study | Gynecologic Oncology | 1990 | 844 |
| 6 | Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging | Gynecologic Oncology | 2008 | 726 |
| 7 | A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass | Gynecologic Oncology | 2009 | 702 |
| 8 | Uterine sarcomas: A review | Gynecologic Oncology | 2010 | 659 |
| 9 | The Rising Incidence of Adenocarcinoma Relative to Squamous Cell Carcinoma of the Uterine Cervix in the United States—A 24-Year Population-Based Study | Gynecologic Oncology | 2000 | 613 |
| 10 | The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform | Gynecologic Oncology | 2009 | 597 |
| 11 | The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass | Gynecologic Oncology | 2008 | 594 |
| 12 | What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? | Gynecologic Oncology | 2006 | 559 |
| 13 | Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis | Gynecologic Oncology | 2012 | 527 |
| 14 | Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling | Gynecologic Oncology | 1995 | 522 |
| 15 | Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm | Gynecologic Oncology | 2009 | 503 |
| 16 | The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study | Gynecologic Oncology | 1992 | 491 |
| 17 | Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective Study | Gynecologic Oncology | 1998 | 470 |
| 18 | Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999 | Gynecologic Oncology | 2004 | 470 |
| 19 | Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test | Gynecologic Oncology | 2015 | 442 |
| 20 | Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy☆ | Gynecologic Oncology | 2003 | 434 |
| 21 | Therapeutic efficacy of the α-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model | Gynecologic Oncology | 1992 | 433 |
| 22 | Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study | Gynecologic Oncology | 2008 | 431 |
| 23 | α-Particle Radiotherapy with 211At-Labeled Monodisperse Polymer Particles, 211At-Labeled IgG Proteins, and Free 211At in a Murine Intraperitoneal Tumor Model | Gynecologic Oncology | 1995 | 429 |
| 24 | The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma: A potential new form of therapy | Gynecologic Oncology | 1989 | 426 |
| 25 | Uterine Papillary Serous Carcinoma: Patterns of Metastatic Spread | Gynecologic Oncology | 1994 | 423 |
| 26 | Distribution of intraperitoneally injected microspheres labeled with the α-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice | Gynecologic Oncology | 1992 | 418 |
| 27 | Natural history and epidemiology of HPV infection and cervical cancer | Gynecologic Oncology | 2008 | 401 |
| 28 | Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer | Gynecologic Oncology | 2004 | 400 |
| 29 | Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva | Gynecologic Oncology | 1990 | 396 |
| 30 | The Wnt/β-catenin pathway in ovarian cancer: A review | Gynecologic Oncology | 2013 | 394 |
| 31 | Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part II | Gynecologic Oncology | 2016 | 377 |
| 32 | The epidemiology of endometrial cancer | Gynecologic Oncology | 1991 | 376 |
| 33 | Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study | Gynecologic Oncology | 2003 | 374 |
| 34 | Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance | Gynecologic Oncology | 2015 | 374 |
| 35 | Folate receptor alpha as a tumor target in epithelial ovarian cancer | Gynecologic Oncology | 2008 | 365 |
| 36 | Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part I | Gynecologic Oncology | 2016 | 360 |
| 37 | Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers | Gynecologic Oncology | 2008 | 359 |
| 38 | Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients | Gynecologic Oncology | 1998 | 355 |
| 39 | The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodes | Gynecologic Oncology | 2012 | 353 |
| 40 | Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques | Gynecologic Oncology | 2008 | 351 |
| 41 | A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group study | Gynecologic Oncology | 1989 | 350 |
| 42 | Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds | Gynecologic Oncology | 1990 | 350 |
| 43 | Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers | Gynecologic Oncology | 2006 | 349 |
| 44 | Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review | Gynecologic Oncology | 2012 | 348 |
| 45 | Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases | Gynecologic Oncology | 2003 | 347 |
| 46 | The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center | Gynecologic Oncology | 2006 | 347 |
| 47 | Pathology and epidemiology of HPV infection in females | Gynecologic Oncology | 2010 | 347 |
| 48 | Class II versus Class III Radical Hysterectomy in Stage IB–IIA Cervical Cancer: A Prospective Randomized Study | Gynecologic Oncology | 2001 | 346 |
| 49 | Survival after relapse in patients with endometrial cancer: results from a randomized trial☆ | Gynecologic Oncology | 2003 | 345 |
| 50 | Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review | Gynecologic Oncology | 2003 | 344 |
